Structural Basis for Human Monoglyceride Lipase Inhibition

被引:145
作者
Bertrand, T. [1 ]
Auge, F. [2 ]
Houtmann, J. [1 ]
Rak, A. [1 ]
Vallee, F. [1 ]
Mikol, V. [1 ]
Berne, P. F. [3 ]
Michot, N. [3 ]
Cheuret, D. [2 ]
Hoornaert, C. [2 ]
Mathieu, M. [1 ]
机构
[1] Sanofi Aventis, Dept Biol Struct, F-94403 Vitry Sur Seine, France
[2] Sanofi Aventis, Dept Cent Nervous Syst, F-92220 Bagneux, France
[3] Sanofi Aventis, Dept Biol Sci, F-94403 Vitry Sur Seine, France
关键词
monoglyceride lipase; X-ray structure; inhibitor; CANNABINOID RECEPTOR; MOLECULAR CHARACTERIZATION; MONOACYLGLYCEROL LIPASE; ANANDAMIDE; HYDROLYSIS; ENZYME; 2-ARACHIDONOYLGLYCEROL; BLOCKADE; SITE; ENDOCANNABINOIDS;
D O I
10.1016/j.jmb.2009.11.060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Monoglyceride lipase (MGL) is a serine hydrolase that hydrolyses 2-arachidonoylglycerol (2-AG) into arachidonic acid and glycerol. 2-AG is an endogenous ligand of cannabinoid receptors, involved in various physiological processes in the brain. We present here the first crystal structure of human MGL in its apo form and in complex with the covalent inhibitor SAR629. MGL shares the classic fold of the alpha/beta hydrolase family but depicts an unusually large hydrophobic occluded tunnel with a highly flexible lid at its entry and the catalytic triad buried at its end. Structures reveal the configuration of the catalytic triad and the shape and nature of the binding site of 2-AG. The bound structure of SAR629 highlights the key interactions for productive binding with MGL. The shape of the tunnel suggests a high druggability of the protein and provides an attractive template for drug discovery. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:663 / 673
页数:11
相关论文
共 55 条
[1]
THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension [J].
Bátkai, S ;
Pacher, P ;
Osei-Hyiaman, D ;
Radaeva, S ;
Liu, J ;
Harvey-White, J ;
Offertáler, L ;
Mackie, K ;
Rudd, MA ;
Bukoski, RD ;
Kunos, G .
CIRCULATION, 2004, 110 (14) :1996-2002
[3]
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol [J].
Beltramo, M ;
Piomelli, D .
NEUROREPORT, 2000, 11 (06) :1231-1235
[4]
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation [J].
Bifulco, M ;
Laezza, C ;
Valenti, M ;
Ligresti, A ;
Portella, G ;
Di Marzo, V .
FASEB JOURNAL, 2004, 18 (11) :1606-+
[5]
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol [J].
Blankman, Jacqueline L. ;
Simon, Gabriel M. ;
Cravatt, Benjamin F. .
CHEMISTRY & BIOLOGY, 2007, 14 (12) :1347-1356
[6]
Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling [J].
Bracey, MH ;
Hanson, MA ;
Masuda, KR ;
Stevens, RC ;
Cravatt, BF .
SCIENCE, 2002, 298 (5599) :1793-1796
[7]
DIRECT PHASE DETERMINATION BY ENTROPY MAXIMIZATION AND LIKELIHOOD RANKING - STATUS-REPORT AND PERSPECTIVES [J].
BRICOGNE, G .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1993, 49 :37-60
[8]
Bricogne G, 1997, METHOD ENZYMOL, V277, P14, DOI 10.1016/S0076-6879(97)77004-6
[9]
A MODEL FOR INTERFACIAL ACTIVATION IN LIPASES FROM THE STRUCTURE OF A FUNGAL LIPASE-INHIBITOR COMPLEX [J].
BRZOZOWSKI, AM ;
DEREWENDA, U ;
DEREWENDA, ZS ;
DODSON, GG ;
LAWSON, DM ;
TURKENBURG, JP ;
BJORKLING, F ;
HUGEJENSEN, B ;
PATKAR, SA ;
THIM, L .
NATURE, 1991, 351 (6326) :491-494
[10]
Fatty acid amide hydrolase controls mouse intestinal motility in vivo [J].
Capasso, R ;
Matias, I ;
Lutz, B ;
Borrelli, F ;
Capasso, F ;
Marsicano, G ;
Mascolo, N ;
Petrosino, S ;
Monory, K ;
Valenti, M ;
Di Marzo, V ;
Izzo, AA .
GASTROENTEROLOGY, 2005, 129 (03) :941-951